plerixafor has been researched along with Chronic Esophagitis, Eosinophilic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardazzi, C; Bozza, MT; Bucala, R; Buongusto, F; Castelo-Branco, MT; de Souza, HS; Elia, CC; Figueiredo, RT; Leng, L; Lintomen, L; Madi, K; Tortori, CA | 1 |
1 trial(s) available for plerixafor and Chronic Esophagitis, Eosinophilic
| Article | Year |
|---|---|
Macrophage migration inhibitory factor promotes eosinophil accumulation and tissue remodeling in eosinophilic esophagitis.
Topics: Adolescent; Adult; Animals; Benzylamines; Cyclams; Eosinophilic Esophagitis; Eosinophils; Female; Heterocyclic Compounds; Humans; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Male; Mice; Mice, Knockout; Middle Aged; Mucous Membrane; Receptors, CXCR4 | 2015 |